Unstable angina/ NSTEMI resident survival guide: Difference between revisions

Jump to navigation Jump to search
Line 46: Line 46:
❑ Discontinue with GP inhibitors <br> ❑ UFH (for 48hrs) or Enoxiparin (for 8 dyas)}}
❑ Discontinue with GP inhibitors <br> ❑ UFH (for 48hrs) or Enoxiparin (for 8 dyas)}}
{{familytree  | |,|-|^|-|.| |!| | | | | | | |!| }}
{{familytree  | |,|-|^|-|.| |!| | | | | | | |!| }}
{{familytree  | H01 | | H02 |!| | | | | | | |!| H01= NO | H02= ❑ heart faillure <br> ❑ serious arrhythmias ❑ subsequent isquemia}}
{{familytree  | H01 | | H02 |!| | | | | | | |!| H01= NO | H02= ❑ heart faillure <br> ❑ serious arrhythmias <br> ❑ subsequent isquemia}}
{{familytree  | |!| | | |!| |!| | | | | |,|-|^|-|.| }}
{{familytree  | |!| | | |!| |!| | | | | |,|-|^|-|.| }}
{{familytree  | I01 | | |!| |!| | | | | I02 | | I03 | | | I01= Continue Aspirin <br> ❑ Continue with clopidrogel or ticagelor for 12 months <br>
{{familytree  | I01 | | |!| |!| | | | | I02 | | I03 | | | I01= Continue Aspirin <br> ❑ Continue with clopidrogel or ticagelor for 12 months <br>
❑ Discontinue with GP inhibitors <br> ❑ UFH (for 48hrs) or Enoxiparin (for 8 dyas|
❑ Discontinue with GP inhibitors <br> ❑ UFH (for 48hrs) or Enoxiparin (for 8 dyas|
I02= | I03= }}
I02= PCI <br>
❑ Administer clopidogrel 24 hrs before <br>
❑ As as possible in no bleeding risk patients who are unstable or with high risk of isquemia <br>
❑ Administer UFH (50-100 units/kg)
| I03= CABG <BR>
❑  Continue aspirin + UFH <br>
❑ Discontinue clopidogel 5 days before <br>
❑ Discontinue enoxiparin and fondoparinaux 12-24 hrs before <br>
❑ Discontinue IV GP inhibitors 4 hrs bfore <br>
❑ Discontinue bivalirudin 3 hrs before }}
{{familytree  | | | | | | J01 | | | | | | | | | J01= INTENSIVE STRATEGY - ANGIOGRAPHY }}
{{familytree  | | | | | | J01 | | | | | | | | | J01= INTENSIVE STRATEGY - ANGIOGRAPHY }}
{{familytree  | | | |,|-|-|^|-|-|.| | | | | | | }}
{{familytree  | | | |,|-|-|^|-|-|.| | | | | | | }}
Line 56: Line 65:
{{familytree  | | | |!| | | |,|-|^|-|.| | | | }}
{{familytree  | | | |!| | | |,|-|^|-|.| | | | }}
{{familytree  | | | L01 | | L02 | | L03 | | | L01= ❑ Continue Aspirin <br> ❑ Continue with clopidrogel or ticagelor for 12 months <br>
{{familytree  | | | L01 | | L02 | | L03 | | | L01= ❑ Continue Aspirin <br> ❑ Continue with clopidrogel or ticagelor for 12 months <br>
❑ Discontinue with GP inhibitors <br> ❑ UFH (for 48hrs) or Enoxiparin (for 8 dyas) | L02= | L03=}}
❑ Discontinue with GP inhibitors <br> ❑ UFH (for 48hrs) or Enoxiparin (for 8 dyas)
| L02= PCI <br>
❑ Administer clopidogrel 24 hrs before <br>
❑ As as possible in no bleeding risk patients who are unstable or with high risk of isquemia <br>
❑ Administer UFH (50-100 units/kg)
| L03= CABG <BR>
❑ Continue aspirin + UFH <br>
❑ Discontinue clopidogel 5 days before <br>
❑ Discontinue enoxiparin and fondoparinaux 12-24 hrs before <br>
❑ Discontinue IV GP inhibitors 4 hrs bfore <br>
❑ Discontinue bivalirudin 3 hrs before}}
{{familytree/end}}
{{familytree/end}}



Revision as of 17:18, 27 January 2014

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Definition

Causes

Life Threatening Causes

Common Causes

Management

Diagnosis

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Treatment

 
 
 
 
 
 
 
 
❑ Administer 300mg Aspirin immediately after hospital admission

❑ Administer oxygen in patients with saturation <90%
❑ Administer nitroglycerine sub-lingual ADD DOSES
❑ Administer morphine IV initial dose 2-4mg with increments of 2-8mg every 5 to 15 minutes
❑ Administer beta-blockers to all patients without contraindications
❑ Administer statins, atorvastatine 80mg

❑ Initiate anti thrombotic therapy
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Determine Risk of adverse coronary event (TIMI)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
LOW RISK
Initial conservative strategy
 
 
 
 
 
HIGH RISK
Initial invasive strategy
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
❑ Administer 300mg of copidogrel
❑ Administer fondoparinaux or UFH in case of renal failure
 
 
 
 
 
❑ Administer IV GP IIb/IIIa inhibitors (eptifibatide or tirofiban)
OR
❑ Administer Bivalirudin
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Perform a Stress test
 
 
 
 
 
Angiography
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
LOW RISK
 
HIGH RISK
 
NEGATIVE
 
POSITIVE
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Recurrent symptoms?
 
 
 
 
 
 
❑ Continue Aspirin
❑ Continue with clopidrogel or ticagelor for 12 months
❑ Discontinue with GP inhibitors
❑ UFH (for 48hrs) or Enoxiparin (for 8 dyas)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
NO
 
❑ heart faillure
❑ serious arrhythmias
❑ subsequent isquemia
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Continue Aspirin
❑ Continue with clopidrogel or ticagelor for 12 months
❑ Discontinue with GP inhibitors
❑ UFH (for 48hrs) or Enoxiparin (for 8 dyas
 
 
 
 
 
 
 
 
 
 
 
PCI

❑ Administer clopidogrel 24 hrs before
❑ As as possible in no bleeding risk patients who are unstable or with high risk of isquemia

❑ Administer UFH (50-100 units/kg)
 
CABG

❑ Continue aspirin + UFH
❑ Discontinue clopidogel 5 days before
❑ Discontinue enoxiparin and fondoparinaux 12-24 hrs before
❑ Discontinue IV GP inhibitors 4 hrs bfore

❑ Discontinue bivalirudin 3 hrs before
 
 
 
 
 
 
 
INTENSIVE STRATEGY - ANGIOGRAPHY
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
NEGATIVE
 
 
 
POSITIVE
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
❑ Continue Aspirin
❑ Continue with clopidrogel or ticagelor for 12 months
❑ Discontinue with GP inhibitors
❑ UFH (for 48hrs) or Enoxiparin (for 8 dyas)
 
PCI

❑ Administer clopidogrel 24 hrs before
❑ As as possible in no bleeding risk patients who are unstable or with high risk of isquemia

❑ Administer UFH (50-100 units/kg)
 
CABG

❑ Continue aspirin + UFH
❑ Discontinue clopidogel 5 days before
❑ Discontinue enoxiparin and fondoparinaux 12-24 hrs before
❑ Discontinue IV GP inhibitors 4 hrs bfore

❑ Discontinue bivalirudin 3 hrs before
 
 

References


Template:WikiDoc Sources